| 1 |
34753803 |
10.1158/1541-7786.MCR-21-0208 |
2022 |
MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer. |
BCL10 |
| 2 |
34783281 |
10.1080/10428194.2021.1999444 |
2022 |
Targeting MALT1 for the treatment of diffuse large B-cell lymphoma. |
BCL10 |
| 3 |
34906687 |
10.1016/j.fsi.2021.12.009 |
2022 |
BCL10 regulates the production of proinflammatory cytokines by activating MAPK-NF-κB/Rel signaling pathway in oysters. |
BCL10 |
| 4 |
35099607 |
10.1007/s00018-022-04154-z |
2022 |
A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells. |
BCL10 |
| 5 |
35192832 |
10.1016/j.scitotenv.2022.153990 |
2022 |
Effects of gestational exposure to bisphenol A on the hepatic transcriptome and lipidome of rat dams: Intergenerational comparison of effects in the offspring. |
BCL10 |
| 6 |
35218741 |
10.1016/j.bcp.2022.114977 |
2022 |
Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases. |
BCL10 |
| 7 |
35230873 |
10.1126/scisignal.abk3083 |
2022 |
Phosphorylation of serine-893 in CARD11 suppresses the formation and activity of the CARD11-BCL10-MALT1 complex in T and B cells. |
BCL10 |
| 8 |
35255409 |
10.1016/j.jbior.2022.100890 |
2022 |
CARD11 signaling in regulatory T cell development and function. |
BCL10 |
| 9 |
35406516 |
10.3390/cancers14071742 |
2022 |
Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment. |
BCL10 |
| 10 |
35411950 |
10.1002/cbf.3702 |
2022 |
USP7 sustains an active epigenetic program via stabilizing MLL2 and WDR5 in diffuse large B-cell lymphoma. |
BCL10 |
| 11 |
35540095 |
10.1016/j.jacbts.2022.02.004 |
2022 |
CARD9-Mediated Signaling and Cardiovascular Diseases. |
BCL10 |
| 12 |
35600392 |
10.3389/fonc.2022.881801 |
2022 |
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer. |
BCL10 |
| 13 |
35658124 |
10.1158/2159-8290.CD-21-1566 |
2022 |
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL. |
BCL10 |
| 14 |
35727133 |
10.7554/eLife.79826 |
2022 |
A nucleation barrier spring-loads the CBM signalosome for binary activation. |
BCL10 |
| 15 |
35750252 |
10.1016/j.clim.2022.109067 |
2022 |
BCL10 loss-of-function novel mutation leading to atypical severe combined immunodeficiency. |
BCL10 |
| 16 |
35929131 |
10.1158/2159-8290.CD-22-0614 |
2022 |
BCL10 Mutants: Architects of Oncogenic Signaling Provide a Blueprint for Precision Medicine. |
BCL10 |
| 17 |
35981904 |
10.1016/j.jaci.2022.06.023 |
2022 |
The role of the CBM complex in allergic inflammation and disease. |
BCL10 |
| 18 |
36094731 |
10.1007/s12104-022-10105-3 |
2022 |
Assignment of IVL-Methyl side chain of the ligand-free monomeric human MALT1 paracaspase-IgL<sub>3</sub> domain in solution. |
BCL10 |
| 19 |
31595055 |
10.1038/s41423-019-0297-y |
2021 |
Bcl10 is required for the development and suppressive function of Foxp3<sup>+</sup> regulatory T cells. |
BCL10 |
| 20 |
32790937 |
10.1111/febs.15522 |
2021 |
Defining the combinatorial space of PKC::CARD-CC signal transduction nodes. |
BCL10 |
| 21 |
32838054 |
10.1016/j.coemr.2020.07.011 |
2021 |
Subcellular hot spots of GPCR signaling promote vascular inflammation. |
BCL10 |
| 22 |
32855441 |
10.1038/s41379-020-00660-2 |
2021 |
Deciphering the genetic landscape of pulmonary lymphomas. |
BCL10 |
| 23 |
32927162 |
10.1016/j.ecoenv.2020.111272 |
2021 |
Augmented autophagy suppresses thymocytes development via Bcl10/p-p65 pathway in prenatal nicotine exposed fetal mice. |
BCL10 |
| 24 |
33419765 |
10.4049/jimmunol.2001031 |
2021 |
Intrinsic Abnormalities of Keratinocytes Initiate Skin Inflammation through the IL-23/T17 Axis in a MALT1-Dependent Manner. |
BCL10 |
| 25 |
33640899 |
10.1038/s41392-021-00477-8 |
2021 |
TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO. |
BCL10 |
| 26 |
33777778 |
10.3389/fonc.2021.628807 |
2021 |
Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma. |
BCL10 |
| 27 |
33872653 |
10.1016/j.jaci.2021.04.006 |
2021 |
Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency. |
BCL10 |
| 28 |
33941870 |
10.1038/s41418-021-00787-y |
2021 |
USP12 promotes CD4<sup>+</sup> T cell responses through deubiquitinating and stabilizing BCL10. |
BCL10 |
| 29 |
34014917 |
10.1371/journal.pcbi.1007986 |
2021 |
Signaling through polymerization and degradation: Analysis and simulations of T cell activation mediated by Bcl10. |
BCL10 |
| 30 |
34192836 |
10.1515/hsz-2021-0250 |
2021 |
The paracaspase MALT1 in psoriasis. |
BCL10 |
| 31 |
34236636 |
10.1007/978-1-0716-1669-7_8 |
2021 |
Methods to Study CARD11-BCL10-MALT1 Dependent Canonical NF-κB Activation in Jurkat T Cells. |
BCL10 |
| 32 |
34412631 |
10.1186/s12935-021-02143-z |
2021 |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling. |
BCL10 |
| 33 |
34481211 |
10.1016/j.prp.2021.153593 |
2021 |
Bcl-10, trypsin and synaptophysin helps recognize acinar cell and mixed acinar neuroendocrine cell carcinoma of the pancreas on both preoperative cytological samples and needle biopsy specimens. |
BCL10 |
| 34 |
34499781 |
10.1111/pin.13164 |
2021 |
Primary pure pancreatic-type acinar cell carcinoma of the stomach. |
BCL10 |
| 35 |
34826258 |
10.1126/sciimmunol.abi4425 |
2021 |
Keratinocyte-intrinsic BCL10/MALT1 activity initiates and amplifies psoriasiform skin inflammation. |
BCL10 |
| 36 |
34868072 |
10.3389/fimmu.2021.786572 |
2021 |
Clinical and Immunological Features of Human BCL10 Deficiency. |
BCL10 |
| 37 |
34879060 |
10.1371/journal.pntd.0010029 |
2021 |
Deep resequencing identifies candidate functional genes in leprosy GWAS loci. |
BCL10 |
| 38 |
34928543 |
10.1002/iub.2581 |
2021 |
BCL10 correlates with bad prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma. |
BCL10 |
| 39 |
31241148 |
10.1093/cvr/cvz169 |
2020 |
B-cell lymphoma/leukaemia 10 and angiotensin II-induced kidney injury. |
BCL10 |
| 40 |
31751629 |
10.1016/j.dci.2019.103555 |
2020 |
The signaling relations between three adaptors of porcine C-type lectin receptor pathway. |
BCL10 |
| 41 |
31757436 |
10.1016/j.pathol.2019.08.012 |
2020 |
Marginal zone B-cell lymphoma: lessons from Western and Eastern diagnostic approaches. |
BCL10 |
| 42 |
31774199 |
10.15252/embj.2019102030 |
2020 |
Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis. |
BCL10 |
| 43 |
31808815 |
10.1093/cvr/cvz320 |
2020 |
A complex role for Bcl10 in kidney injury. |
BCL10 |
| 44 |
31883669 |
10.1016/j.pathol.2019.09.014 |
2020 |
The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma. |
BCL10 |
| 45 |
31961340 |
10.1172/JCI97040 |
2020 |
GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein. |
BCL10 |
| 46 |
32008135 |
10.1007/s10875-020-00760-3 |
2020 |
Human BCL10 Deficiency due to Homozygosity for a Rare Allele. |
BCL10 |
| 47 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
BCL10 |
| 48 |
32164050 |
10.4143/crt.2019.606 |
2020 |
Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway. |
BCL10 |
| 49 |
32179489 |
10.1016/j.cancergen.2020.02.005 |
2020 |
Integrating transcriptome-wide association study and copy number variation study identifies candidate genes and pathways for diffuse non-Hodgkin's lymphoma. |
BCL10 |
| 50 |
32343482 |
10.15252/embr.201949237 |
2020 |
MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice. |
BCL10 |
| 51 |
32388054 |
10.1016/j.cellimm.2020.104115 |
2020 |
TAK1 lessens the activity of the paracaspase MALT1 during T cell receptor signaling. |
BCL10 |
| 52 |
32450431 |
10.1016/j.cellimm.2020.104133 |
2020 |
The LUBAC participates in lysophosphatidic acid-induced NF-κB activation. |
BCL10 |
| 53 |
32574386 |
10.1111/ejh.13467 |
2020 |
MALT-1 as a novel therapeutic target for adult T-cell leukemia. |
BCL10 |
| 54 |
32593012 |
10.1016/j.cellimm.2020.104147 |
2020 |
Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease. |
BCL10 |
| 55 |
32683230 |
10.1016/j.jtemb.2020.126615 |
2020 |
Zinc homeostasis plays an important role in the prevention of obesity-induced cardiac inflammation, remodeling and dysfunction. |
BCL10 |
| 56 |
32721634 |
10.1016/j.cellimm.2020.104158 |
2020 |
Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist. |
BCL10 |
| 57 |
32768663 |
10.1016/j.cellimm.2020.104161 |
2020 |
Bcl10 is associated with actin dynamics at the T cell immune synapse. |
BCL10 |
| 58 |
32771677 |
10.1016/j.cellimm.2020.104189 |
2020 |
The CBM complex: A growing multiplicity of cellular functions, regulatory mechanisms and connections to human disease. |
BCL10 |
| 59 |
33052237 |
10.7150/thno.47533 |
2020 |
Targeting BCL10 by small peptides for the treatment of B cell lymphoma. |
BCL10 |
| 60 |
33202260 |
10.1016/j.ajhg.2020.10.015 |
2020 |
Multiplexed Functional Assessment of Genetic Variants in CARD11. |
BCL10 |
| 61 |
33297339 |
10.3390/nu12123755 |
2020 |
Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells. |
BCL10 |
| 62 |
33329596 |
10.3389/fimmu.2020.601926 |
2020 |
Cellular and Mathematical Analyses of LUBAC Involvement in T Cell Receptor-Mediated NF-κB Activation Pathway. |
BCL10 |
| 63 |
30514565 |
10.1016/j.cellimm.2018.11.001 |
2019 |
Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells. |
BCL10 |
| 64 |
30660642 |
10.1016/j.jaci.2018.12.1000 |
2019 |
Double-strand break repair through homologous recombination in autosomal-recessive BCL10 deficiency. |
BCL10 |
| 65 |
30773504 |
10.5582/bst.2018.01291 |
2019 |
By regulating miR-182-5p/BCL10/CYCS, sufentanil reduces the apoptosis of umbilical cord mesenchymal stem cells caused by ropivacaine. |
BCL10 |
| 66 |
31047877 |
10.1016/j.cca.2019.04.077 |
2019 |
BCL10 in cell survival after DNA damage. |
BCL10 |
| 67 |
31060714 |
10.1016/j.jaci.2019.03.009 |
2019 |
Germline CBM-opathies: From immunodeficiency to atopy. |
BCL10 |
| 68 |
31077220 |
10.1186/s13000-019-0815-3 |
2019 |
Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report. |
BCL10 |
| 69 |
31092922 |
10.1038/s41586-019-1215-2 |
2019 |
Targeting the CBM complex causes T<sub>reg</sub> cells to prime tumours for immune checkpoint therapy. |
BCL10 |
| 70 |
31138793 |
10.1038/s41467-019-10203-2 |
2019 |
Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells. |
BCL10 |
| 71 |
31178130 |
10.1016/j.bbrc.2019.06.004 |
2019 |
ZNF436 promotes tumor cell proliferation through transcriptional activation of BCL10 in glioma. |
BCL10 |
| 72 |
31179345 |
10.1155/2019/9582714 |
2019 |
Distinct Effects of Carrageenan and High-Fat Consumption on the Mechanisms of Insulin Resistance in Nonobese and Obese Models of Type 2 Diabetes. |
BCL10 |
| 73 |
31296852 |
10.1038/s41467-019-10953-z |
2019 |
Structures of autoinhibited and polymerized forms of CARD9 reveal mechanisms of CARD9 and CARD11 activation. |
BCL10 |
| 74 |
31391255 |
10.1074/jbc.RA119.009551 |
2019 |
Coordinated regulation of scaffold opening and enzymatic activity during CARD11 signaling. |
BCL10 |
| 75 |
31420608 |
10.1038/s41388-019-0958-4 |
2019 |
MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types. |
BCL10 |
| 76 |
31427546 |
|
2019 |
Characterisation of immunogenotypes of diffuse large B-cell lymphoma. |
BCL10 |
| 77 |
31554683 |
10.1128/JVI.01499-19 |
2019 |
Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons. |
BCL10 |
| 78 |
31644910 |
10.1016/j.celrep.2019.09.040 |
2019 |
MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells. |
BCL10 |
| 79 |
31658764 |
10.3390/ijms20205022 |
2019 |
B-Cell Activating Factor Enhances Hepatocyte-Driven Angiogenesis via B-Cell CLL/Lymphoma 10/Nuclear Factor-KappaB Signaling during Liver Regeneration. |
BCL10 |
| 80 |
28886618 |
10.1111/cmi.12788 |
2018 |
Bcl10 synergistically links CEACAM3 and TLR-dependent inflammatory signalling. |
BCL10 |
| 81 |
29259013 |
10.1158/0008-5472.CAN-17-1089 |
2018 |
The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer. |
BCL10 |
| 82 |
29289361 |
10.1016/j.blre.2017.12.001 |
2018 |
The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies. |
BCL10 |
| 83 |
29358699 |
10.1038/s41598-018-19822-z |
2018 |
GSK3β modulates NF-κB activation and RelB degradation through site-specific phosphorylation of BCL10. |
BCL10 |
| 84 |
29382759 |
10.1073/pnas.1721967115 |
2018 |
Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome. |
BCL10 |
| 85 |
29649481 |
10.1016/j.bbrc.2018.04.057 |
2018 |
Role of IκB kinase β in regulating the remodeling of the CARMA1-Bcl10-MALT1 complex. |
BCL10 |
| 86 |
29765142 |
10.1038/s41379-018-0064-0 |
2018 |
Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement. |
BCL10 |
| 87 |
29881386 |
10.3389/fimmu.2018.01136 |
2018 |
Ancient Origin of the CARD-Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions. |
BCL10 |
| 88 |
29925955 |
10.1038/s41586-018-0290-0 |
2018 |
A multiprotein supercomplex controlling oncogenic signalling in lymphoma. |
BCL10 |
| 89 |
29953499 |
10.1371/journal.pone.0199779 |
2018 |
Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells. |
BCL10 |
| 90 |
30022982 |
10.3389/fimmu.2018.01539 |
2018 |
BCL10 - Bridging CARDs to Immune Activation. |
BCL10 |
| 91 |
30206119 |
10.1074/jbc.RA118.004821 |
2018 |
Picomolar zinc binding modulates formation of Bcl10-nucleating assemblies of the caspase recruitment domain (CARD) of CARD9. |
BCL10 |
| 92 |
30214442 |
10.3389/fimmu.2018.01927 |
2018 |
Holding All the CARDs: How MALT1 Controls CARMA/CARD-Dependent Signaling. |
BCL10 |
| 93 |
30279415 |
10.1038/s41467-018-06573-8 |
2018 |
Molecular architecture and regulation of BCL10-MALT1 filaments. |
BCL10 |
| 94 |
30283440 |
10.3389/fimmu.2018.02078 |
2018 |
The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex. |
BCL10 |
| 95 |
30283447 |
10.3389/fimmu.2018.02105 |
2018 |
Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease. |
BCL10 |
| 96 |
30336982 |
10.1016/j.bbrc.2018.10.029 |
2018 |
MALT1 activation by TRAF6 needs neither BCL10 nor CARD11. |
BCL10 |
| 97 |
30386326 |
10.3389/fimmu.2018.02239 |
2018 |
Clinical and Genetic Heterogeneity of <i>CARD14</i> Mutations in Psoriatic Skin Disease. |
BCL10 |
| 98 |
30401751 |
10.1182/bloodadvances.2018022962 |
2018 |
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia. |
BCL10 |
| 99 |
30429846 |
10.3389/fimmu.2018.02366 |
2018 |
A <i>CARD9</i> Founder Mutation Disrupts NF-κB Signaling by Inhibiting BCL10 and MALT1 Recruitment and Signalosome Formation. |
BCL10 |
| 100 |
30446641 |
10.1038/s41467-018-07215-9 |
2018 |
Cellular metabolism constrains innate immune responses in early human ontogeny. |
BCL10 |
Datasets
Models
